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ABSTRACT 
 
Objectives: Neurofunctional alterations are correlates of vulnerability to psychosis, as well 
as of the disorder itself. However, neurofunctional abnormalities within the ARMS, and how 
they relate to different probabilities for later transition to psychosis is unclear. We 
investigated neurofunctional abnormalities during working memory processing in individuals 
with an at-risk mental state (ARMS).  
 
Experimental design: Patients with ‘first-episode psychosis’ (FEP, n=21), short-term 
ARMS (ARMS-ST, n=17), long-term ARMS (ARMS-LT, n=16), and healthy controls (HC, 
n=20) were investigated with an n-back working memory task. We examined functional 
(fMRI) and structural magnetic resonance imaging (sMRI) data in conjunction using 
Biological Parametric Mapping (BPM) toolbox. 
 
Principal observations: There were no differences in accuracy, but the FEP and the ARMS-
ST group had longer reaction times compared to the HC and the ARMS-LT group. With the 
2-back>0-back contrast we found reduced functional activation in ARMS-ST and FEP 
compared to the HC group in parietal and middle frontal regions. Relative to ARMS-LT 
individuals, FEP patients showed decreased activation in the bilateral inferior frontal gyrus 
and insula, and in the left prefrontal cortex. Compared to the ARMS-LT, the ARMS-ST 
subjects showed reduced activation in the right inferior frontal gyrus and insula. Reduced 
insular and prefrontal activation was associated with gray matter volume reduction in the 
same area in the ARMS-LT group.  
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Conclusions: These findings suggest that vulnerability to psychosis was associated with 
neurofunctional alterations in fronto-temporo-parietal networks in a working memory task.  
Neurofunctional differences within the ARMS were related to different duration of the 
prodromal state and resilience factors. 
 
Keywords: 
ultra-high-risk (UHR), at-risk mental state (ARMS), schizophrenia, working memory, fMRI 
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INTRODUCTION 
 
Neurofunctional alterations are a leading feature of psychosis. To date, it is not clear to what 
extent these abnormalities correlate with vulnerability to psychosis or pathology of the 
disorder itself. However, for the understanding of their pathogeneses it is important to clarify 
their onset and time course of the dynamic neurobiological processes underlying the 
transition from a high-risk state to manifest psychosis.  
Working memory (WM) impairment is one of the most pronounced cognitive features found 
in schizophrenia (Callicott et al., 2003b; Cannon et al., 2005; Forbes et al., 2009; Glahn et 
al., 2005; Jansma et al., 2004; Johnson et al., 2006; Manoach et al., 2000; Menon et al., 2001; 
Schneider et al., 2007). Impairments in the WM network activation depend on the individual 
performance, higher performing patients with schizophrenia showed hyper-activation and 
lower performing patients showed hypo-activation what was explained using the 
compensation model of activation (Sanz et al., 2009). However, the relation of physiological 
and clinical variables (positive, negative symptoms) is complicated by the multidimensional 
nature of psychotic symptoms. Recent advances in psychiatric research indicate that 
neurocognitive deficits are also evident in subjects with an at-risk mental state (ARMS) 
(Eastvold et al., 2007; Pflueger et al., 2007; Simon et al., 2007; Smith et al., 2006) and in 
non-affected first-degree relatives (Karch et al., 2009; Karlsgodt et al., 2007; Lee et al., 
2010a; MacDonald et al., 2009; Meda et al., 2008; Spence et al., 2000).  
The ARMS is defined according to the PACE (Personal Assessment and Crisis Evaluation 
Clinic, Melbourne) criteria and requires individuals to present attenuated positive psychotic 
or brief limited intermittent symptoms that do not reach full psychosis threshold (Riecher-
Rossler et al., 2007; Riecher-Rossler et al., 2009; Yung et al., 2004) or functional decline. 
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These psychopathological symptoms are often associated with negative (Lencz et al., 2004; 
Riecher-Rossler et al., 2009) symptoms, subtle cognitive deficits (Brewer et al., 2006; 
Riecher-Rossler et al., 2009) and include deficits in working memory function (Broome et 
al., 2010; Simon et al., 2007). Those with the ARMS have a 20–40% probability of 
developing the psychosis (Riecher-Rossler et al., 2007; Riecher-Rossler et al., 2009; Yung et 
al., 1998). Furthermore, neurofunctional deficits may be associated with transition to 
psychosis and thus can be seen as vulnerability markers for developing schizophrenia 
(Morey et al., 2005; Riecher-Rossler et al., 2009).  
Over the past decade, structural (sMRI) and functional magnetic resonance imaging (fMRI) 
methods have been extensively employed to identify the anatomical and neurofunctional 
alterations in the pre-psychotic phases. In subjects at high-risk for psychosis, MRI studies 
showed structural abnormalities (Borgwardt et al., 2007a; Borgwardt et al., 2008; Borgwardt 
et al., 2006; Borgwardt et al., 2007b; Koutsouleris et al., 2009; Meisenzahl et al., 2008; 
Pantelis et al., 2003; Witthaus et al., 2009) and neurofunctional deficits in the frontal and 
temporal task-related networks (Allen et al., 2010; Fusar-Poli et al., 2007), especially during 
working memory tasks (Broome et al., 2010; Broome et al., 2009; Pauly et al., 2010). Such 
alterations are not only attributable to the effects of illness or treatment and may represent 
markers of vulnerability to psychosis (Smieskova et al., 2010).  
Since 1999, the Early Detection of Psychosis Clinic (FEPSY) in Basel recruited and 
followed up the ARMS individuals over up to 7 years (Riecher-Rossler et al., 2009). 
Importantly, 19 of those 21 ARMS individuals who made transition, transit in the first two 
years after their ascertainment. Afterwards, only 2 out of 53 included ARMS individuals 
made transition to psychosis (Riecher-Rossler et al., 2009) representing a reduced transition 
probability. Similarly, the vast majority of transitions occur in the first two years (estimated 
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hazard ratio 0.58) and significantly dropped over time (estimated hazard ratio 0.07) (Yung et 
al., 2007). In the present study, we therefore investigated the ARMS individuals with a short 
or long duration of the ARMS. All these individuals fulfil the ARMS criteria (similar to the 
PACE criteria) at the time of scan. In the first group (short-term ARMS, ARMS-ST), the 
scan was done at the time of ascertainment of the ARMS (within 3 months on average). In 
the second group (long-term ARMS, ARMS-LT), the scan was done after 2 years, on 
average 4.5 years of follow-up with no transition to psychosis. At the time of the scan in the 
latter group, the assessment of the ARMS was repeated and PACE criteria were still met. We 
thus investigated two ARMS subgroups both representing vulnerability to psychosis with 
different probabilities of later transition to psychosis. It is important to emphasise that also 
ARMS-LT group continue to meet ARMS criteria at the time of scan. This group is therefore 
clearly on the risk continuum to develop psychosis, but according to the published data has 
lower probability to develop subsequent psychosis than ARMS-ST. In this context, we aimed 
to examine the neurofunctional brain abnormalities associated with higher vs. lower 
probability of developing psychosis. This could improve our understanding of the 
neurofunctional changes in the mental state in early stages in the context of clinical staging 
model (McGorry et al., 2009).  
Until now, there is a small number of fMRI studies in people with an ARMS (Broome et al., 
2010; Broome et al., 2009; Fusar-Poli et al., 2010a; Fusar-Poli et al., 2010b) investigating 
neurofunctional abnormalities while performing a working memory task. 
Expanding previous study (Broome et al., 2009), here we investigated an ARMS-LT group 
with a lower probability of developing psychosis compared to the ARMS-ST group (Yung et 
al., 2007).  
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Additionally, we focused on functional and structural differences between individuals with 
vulnerability to develop psychosis and already psychotic individuals (patients with first-
episode psychosis, FEP).  
On the basis of previous findings (Broome et al., 2009), we tested the following hypotheses: 
1. The WM-specific activation would be diminished in parallel with the clinical status 
(ARMS-LT<ARMS-ST<FEP) compared to the healthy control (HC) group.  
2. The ARMS-ST group would show more functional deficits associated with volumetric 
abnormalities compared to the ARMS-LT group.  
 
MATERIALS AND METHODS  
 
Subjects 
MRI data were collected as part of a research programme on early detection of psychosis that 
is described in detail elsewhere (Riecher-Rossler et al., 2006). Briefly, we recruited subjects 
with an ARMS and patients experiencing a FEP in our specialised clinic for the early 
detection of psychosis at the Psychiatric Outpatient Department, Psychiatric University 
Clinics Basel, Switzerland.  
The entire group of individuals with an ARMS (ARMS-ST and ARMS-LT; n=33) 
corresponds to the criteria by Yung (Yung et al., 1998) employed in previous MRI studies 
(Borgwardt et al., 2007a; Borgwardt et al., 2007b; Pantelis et al., 2003; Sun et al., 2009; 
Takahashi et al., 2009a; Takahashi et al., 2009b; Velakoulis et al., 2006; Walterfang et al., 
2008; Wood et al., 2003; Wood et al., 2005). All the ARMS individuals were assessed at the 
time of MRI scan. Inclusion thus required one or more of the following a) "attenuated" 
psychotic symptoms b) brief limited intermittent psychotic symptoms (BLIPS) or c) a first 
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degree relative with a psychotic disorder plus at least two indicators of a clinical change, 
such as a marked decline in social or occupational functioning. 
We divided the ARMS individuals into two subgroups depending on the duration of the 
ARMS status since its first presentation. The ARMS-ST group had the MRI scan as soon as 
practicable, on average within 3 months after ascertainment. The ARMS-LT group comprise 
of individuals who did not convert to psychosis over a longer follow up period of on average 
4.5 years after first ascertainment. The mean duration of follow up of ARMS-ST subjects 
was 2.88 months (SD=5.24), with one individual who developed psychosis. The mean follow 
up time since presentation in ARMS-LT subgroup was 55.44 months (SD=24.72). At time of 
scanning all the ARMS-ST and ARMS-LT individuals still fulfilled the criteria by Yung et 
al. for ARMS (Riecher-Rossler et al., 2008; Yung et al., 1998) but had different probabilities 
of developing psychosis (Cannon et al., 2008; Riecher-Rossler et al., 2009; Yung et al., 
2008).   
During follow-up, the ARMS-ST and ARMS-LT subjects received psychiatric case 
management without any antipsychotic treatment. All the ARMS individuals (from both 
groups) were antipsychotic-naïve, except for one subjects who was at the time of scanning 
antipsychotic-free (olanzapine 2.5 mg/day for 9 months; 4 months before the scan) and two 
currently medicated ARMS-LT subjects (1 zuclopenthixol 3x40 mg/day, and 1 aripiprazole 
5mg/day, for unknown period prescribed for treatment of negative symptoms from their 
physician). Furthermore, 8 of ARMS-LT and 6 of ARMS-ST were receiving antidepressants 
at the time of the MRI scan. 
The FEP patients (n=21) were defined as subjects who met the operational criteria for ‘first-
episode psychosis’(Breitborde, 2009). Inclusion required scores of 4 or above on the 
hallucination item or 5 or above on the unusual thought content, suspiciousness or 
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conceptual disorganisation items of the BPRS (Yung et al., 1998). The symptoms must have 
occurred at least several times a week and persisted for more than one week. Most of our 
FEP patients were not receiving medication (7 of them antipsychotic-naïve, 6 antipsychotic-
free) at time of scanning. Eight FEP patients were receiving antipsychotics at the time of 
scanning for approximately 2 months (5 quetiapine and 2 paliperidone for less than 6 
months, 1 olanzapine for less than 2 years).   
We assessed subjects using the ‘Basel Screening Instrument for Psychosis’ (BSIP) (Riecher-
Rossler et al., 2008; Riecher-Rossler et al., 2007), the Brief Psychiatric Rating Scale 
(BPRS)(Lukoff et al., 1986), the Scale for the Assessment of Negative Symptoms 
(SANS)(Andreasen, 1989) and the Global Assessment of Functioning (GAF). The BSIP 
evaluates ‘prodromal’ symptoms (defined according to the Diagnosis and Statistical Manual 
of Mental Disorder, DSM-III-R) occurring in the last 5 years; nonspecific ‘prodromal’ signs 
(Riecher-Rossler et al., 2007) in the last 2 years; previous or current psychotic symptoms, 
psychosocial functioning over the last 5 years, substance dependency; and psychotic 
disorders among first and second degree relatives (Riecher-Rossler et al., 2008) . We 
obtained current and previous psychotropic medication, alcohol, nicotine, cannabis, and 
other illegal drug consumption using a semi-structured interview adapted from Early 
Psychosis Prevention and Intervention Centre (EPPIC) Drug and Alcohol Assessment 
Schedule (www.eppic.org.au).  
We applied the following exclusion criteria to both these groups: history of previous 
psychotic disorder; psychotic symptomatology secondary to an ‘organic’ disorder; substance 
abuse according to ICD-10 research criteria; psychotic symptomatology associated with an 
affective psychosis or a borderline personality disorder; age under 18 years; inadequate 
knowledge of the German language; and IQ (Lehrl et al., 1995) less than 70.  
Smieskova et al. 
 
11
We recruited healthy volunteers (HC, n=20) from the same geographical area as the other 
groups. All subjects were representative of the local population of individuals presenting 
with an ARMS or FEP in terms of age, gender, handedness, and alcohol and cannabis 
consumption. These individuals had no current psychiatric disorder, no history of psychiatric 
illness, head trauma, neurological illness, serious medical or surgical illness, substance 
abuse, and no family history of any psychiatric disorder as assessed by an experienced 
psychiatrist in a detailed clinical semi-structured interview.  
 
Magnetic resonance image acquisition 
Functional MRI 
We acquired the n-back task elicited images on a 3 T scanner (Siemens Magnetom Verio, 
Siemens Healthcare, Erlangen, Germany) using an echo planar sequence with a repetition 
time (TR) of 2.5 s, echo time (TE) of 28 ms, matrix 76x76, 126 volumes and 38 slices with 
0.5 mm interslice gap, providing a resolution of 3x3x3 mm3, and a field of view (FOV) 
228x228 cm2. With an inter-stimulus interval of 2 seconds, all subjects saw the series of 
black letters on the white background in a prismatic mirror. Each stimulus was presented for 
2 seconds. During a baseline (0-back) condition, subjects were required to press the button 
with the right hand when the letter „X” appeared. During 1-back and 2-back conditions, 
participants were instructed to press the button if the currently presented letter was the same 
as that presented 1 (1-back condition) or 2 (2-back condition) trials beforehand. The three 
conditions were presented in 10 alternating 30 s blocks (2 x 1-back, 3 x 2-back and 5 x 0-
back) matched for the number of target letters per block (i.e. 2 or 3), in a pseudo-random 
order. The reaction times and response accuracy were recorded on-line.  
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Structural MRI 
For anatomical imaging a 3D T1-weighted MPRAGE sequence was applied with 1x1x1 mm3 
isotropic spatial resolution and with inversion time of 1000 ms, TR of 8 ms and TE of 3.4 
ms. All scans were screened for gross radiological abnormalities by an experienced 
neuroradiologist. Five individuals were not included to the analyses due to arachnoidal cysts, 
cavernom, cerebellar atrophy and T2 hyperintensities(Borgwardt et al., 2006).  
 
Image analysis 
We analyzed functional MRI data using the Statistical Parametric Mapping software package 
(SPM8; Wellcome Department of Cognitive Neurology, London, United Kingdom). All 
volumes were realigned to the first volume, corrected for motion artefacts, mean adjusted by 
proportional scaling, normalized into standard stereotactic space (template provided by the 
Montreal Neurological Institute), and smoothed using a 8 mm full-width-at half-maximum 
(FWHM) Gaussian kernel. After exclusion of error trials, we convolved the onset times for 
each trial in seconds with a canonical haemodynamic response function.  
We pre-processed all structural images with the Voxel-Based Morphometry (VBM8) toolbox 
(http://dbm.neuro.uni-jena.de/vbm8/) implemented in SPM8. It utilizes New Segmentation 
and DARTEL methods in SPM8. We modulated the segmented tissue maps of gray matter 
(GM) with the Jacobian determinants from the spatial normalization to correct for volume 
changes. We chose the option ’modulation of non-linear effects only‘, which equals the use 
of default modulation (of both affine and non-linear effects) and globally scaling data 
according to the inverse scaling factor due to affine normalization. Finally, we smoothed the 
modulated GM images with an 8-mm FWHM Gaussian kernel.  
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Integration of multimodal imaging data 
We chose the multimodal integrative image analysis to determine if brain abnormalities in 
working memory were associated with volumetric abnormalities in ARMS-ST, ARMS-LT 
and FEP individuals. We used Biological Parametric Mapping (BPM) (Casanova et al., 
2007) toolbox, developed in Matlab and visualized our results in SPM8. Using 1st level 2-
back>0-back contrast images, we provided BPM Analysis of covariance (ANCOVA) 
analyses with all 4 groups in one model. The fMRI data were the primary modality and the 
corresponding VBM data the imaging covariates. We evaluated the impact of the group 
structural differences on the fMRI data on a voxel-wise basis with gray matter volume 
(GMV) as a regressor. To account for age- and sex-specific associations (Elsabagh et al., 
2009) we used age and gender as covariates in the ANCOVA model. We have run the 
integrative analyses twice, one with and one without GMV as covariate to find the regions 
where the group differences were lost due to this covariation. We chose 2-back>0-back 
contrasts as attention-independent modality with higher load level to search differences 
across groups. To specify the WM-associated network of activation, we used the ‘main-
effect of n-back task’ (full-factorial model; p<0.001, FWE-corrected) as a mask for 2nd level 
analyses. The correlation between the blood oxygen level-dependent (BOLD) signal and 
GMV was calculated on a voxel-by-voxel basis with the BPM correlation model (Casanova 
et al., 2007).  
Statistical significance was assessed at the cluster-level using the non-stationary random field 
theory(Hayasaka et al., 2004). The first step of this cluster-level inference strategy consisted 
of identifying spatially contiguous voxels at a threshold of p<0.01, uncorrected (cluster-
forming threshold)(Petersson et al., 1999). Finally, a family-wise error (FWE) corrected 
cluster-extent threshold of p<0.05 was defined in order to infer statistical significance. To 
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provide sufficient details about the present study, we followed the guidelines for reporting an 
fMRI study (Poldrack et al., 2008). 
To label the regions of brain activation MNI coordinates were transformed into Talairach 
space (www.ebire.org/hcnlab/cortical-mapping; Talairach Daemon software; (Mai JK, 
2008)). 
 
Statistical analysis of demographic data 
We examined clinical and socio-demographic differences between groups using one-way 
analysis of variance (ANOVA), F-test, or chi-square test (Table 1). For post-hoc analyses we 
used the least-significant difference (LSD) test. Statistical analyses were performed with the 
Statistical Package for the Social Sciences (SPSS 16.0). 
 
RESULTS 
 
Clinical and demographic characteristics of the sample 
There were no significant differences among our groups with respect to age (P=0.177), 
gender (P=0.245), handedness (P=0.638), IQ (P=0.166), current alcohol (P=0.247) and 
cannabis (P=0.489) consumption. There were significant between group differences in 
positive and negative symptoms, and in global functioning over all our groups. The FEP 
group had more positive symptoms than ARMS-ST (P=0.006), ARMS-LT (P<0.001) and 
HC (P<0.001) groups. The ARMS-ST group showed a higher BPRS (P=0.018) and SANS 
(P=0.015) and a lower GAF (P<0.0001) score compared to the ARMS-LT (Table 1).  
 
TABLE 1 ABOUT HERE 
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N-back task performance 
There was no difference in the accuracy in any of conditions.  Reaction times differed 
significantly between the FEP compared to the HC and ARMS-LT groups and between 
ARMS-ST compared to the HC and ARMS-LT groups (Supplementary table 1). 
 
Gray matter volumes (VBM results) 
The FEP group showed reduced GMV in the anterior cingulo-prefrontal, hippocampal, and 
occipito-cerebellar regions, compared to HC group (P<0.01). Compared to the ARMS-LT, 
the FEP group had temporo-insular volumetric reductions (P<0.005). Compared to the 
ARMS-ST group, FEP had reduced volumes in the fronto-parietal and occipital regions 
(P<0.05). Both the ARMS-ST and ARMS-LT groups had anterior cingular and frontal 
volumetric reductions compared to the HC group (P<0.05). There was more GMV in insula 
in the ARMS-LT group compared to the HC group.  The ARMS-ST showed volumetric 
reductions in the temporal gyrus extending into insula, compared to the ARMS-LT group 
(Supplementary table 2).  
 
N-back fMRI results 
Main effect of task  
The main effect of task (2-back>0-back) in all 74 subjects delineates the network of activated 
areas independent of group. We used this task effect as a mask to constrain subsequent group 
analyses to a working memory network (Supplementary figure). 
 
Integrative image analysis using functional and structural imaging modalities 
Smieskova et al. 
 
16
Vulnerability-associated abnormalities of developing psychosis 
The ARMS-ST group differed from the HC group in activation in the bilateral superior and 
right inferior parietal lobule (P<0.0001), and in the left superior frontal gyrus (P<0.05; Table 
2, Figure 1). The ARMS-LT group showed no significant functional differences compared to 
the HC group. 
 
FIGURE 1 AND TABLE 2 ABOUT HERE 
 
Psychosis-associated abnormalities 
The FEP group showed less brain activation in the bilateral precuneus extending into 
superior parietal lobule and in the left superior and middle frontal gyrus (P<0.0001) 
compared to the HC group. Compared to the ARMS-LT, the FEP group showed reduced 
activation in the bilateral inferior frontal gyrus and insula, in the left superior frontal gyrus, 
and in the middle frontal gyrus (P<0.01; Table 2, Figure 2). Correlation analyses in the FEP 
individuals under BPM confirmed a negative interaction between BOLD response and GMV 
in right precuneus (36 -72 44; P=0.032). There were no significant differences in brain 
activation in the FEP group compared to the ARMS-ST group. 
 
FIGURE 2 ABOUT HERE 
 
Neurofunctional abnormalities associated with high probability to develop psychosis 
Compared to the ARMS-LT, the ARMS-ST subjects showed reduced activation in the right 
inferior frontal gyrus extending into insula (p<0.05) and in the left superior frontal gyrus, insula 
and bilateral precuneus (p<0.1) (Figure 3, Table 2). There was a positive correlation between 
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BOLD response and GMV in left precuneus (-28 -72 24; P=0.003) in the ARMS-ST group; and 
in right insula (42 -18 -10; P=0.015), left inferior frontal gyrus (-32 32 -18; P=0.002), and in right 
lingual gyrus (32 -72 -12; P=0.0001) in ARMS-LT group.  
 
FIGURE 3 ABOUT HERE 
 
Effects of antipsychotic medication on neurofunctional activation 
The analyses were repeated after exclusion of all subjects on antipsychotic medication. With 
exception of one cluster in the right middle frontal gyrus that lost its significance, the same 
set of regions showed significant differences between the FEP and HC groups. The 
differences in brain activation between FEP and ARMS-LT groups remained unchanged with 
one new significant cluster appearing in the left subthalamic and lentiform nuclei (-10 -14 -
6). The results of repeated analyses in ARMS-ST and ARMS-LT groups showed no 
differences in brain activations (Table 2).  
 
DISCUSSION 
 
With a multimodal image analysis we investigated individuals at high-risk of psychosis and 
patients with the established illness in order to differentiate between vulnerability-associated 
and psychosis-associated abnormalities in the neural substrate of working memory function. 
Comparing ARMS-ST and HC revealed that vulnerability to psychosis was associated with a 
reduced activation in the bilateral superior and inferior parietal lobules as well as in the left 
superior frontal gyrus. Compared to ARMS-LT individuals, those with the ARMS-ST 
showed reduced activation in the right insula and inferior frontal gyrus. Comparing the FEP 
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patients to the ARMS-LT subjects revealed that frank psychosis was associated with reduced 
activation in the bilateral inferior frontal gyrus extending into insula, and in left superior, 
inferior and middle frontal gyri.  
 
We recorded the time from the first presentation of subjects with ARMS and divided them 
into two subgroups comparable with the new staging model for psychosis (McGorry et al., 
2009). The mean duration of the ARMS was 4.5 years in the ARMS-LT group; thus the 
probability that any of these subjects would develop psychosis in the future was rather low 
(Cannon et al., 2008; Riecher-Rossler et al., 2009). In the ARMS-ST subjects, we expect a 
transition rate of approximately 30% (Mechelli A, 2010; Riecher-Rossler et al., 2009) in the 
next one–two years. Splitting the ARMS subjects into two groups allows a better 
understanding of a real subsequent probability to develop psychosis. This may help to 
investigate psychosis-associated functional abnormalities in the FEP (individuals with 
psychosis itself) in contrast to the ARMS-LT (individuals with vulnerability but very low 
transition probability to psychosis). This particular comparison removes any psychosis 
specific effects (inherent in the 30% of ARMS who might transit) making the ARMS-LT 
versus FEP comparison a ‘purer’ contrast to psychosis. The ARMS-ST group with 30% 
probability to develop psychosis subsequently was a basis to investigate vulnerability 
connected with higher transition probability-associated changes in brain activation compared 
to the HC. Interestingly, our ARMS-LT did not differ from the ARMS-ST with respect to 
age, even included longer time ago in ARMS. This could be because of small sample sizes 
and needs further investigation. On the other hand, the difference between ARMS-ST and 
ARMS-LT are not attributable to the effect of aging in one of those groups. We can speculate 
that the differences between these two groups in the n-back activation network showed not 
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only disrupted function in the ARMS-ST group, but resilience or protective processes in the 
ARMS-LT group. 
 
The present study was powered to detect group effects on activation rather than on task 
performance. However, the two ARMS groups showed differences in reaction times during the 
most demanding condition. The FEP and ARMS-ST groups needed longer during 2-back 
condition compared to the HC and the ARMS-LT groups. According to the previously published 
studies (Delawalla et al., 2008; Sanz et al., 2009) the FEP and ARMS-ST groups might be lower 
performing and show prefrontal hypo-activation.  However, it may be because all group contrasts 
were based on 2-back > 0-back condition, it means when the task gets harder. Thus, the 
compensation model might predict hypo-activation (Callicott et al., 2003b) due to a ceiling effect 
of “going downwards on the inverted U-shaped curve”. Individuals with more psychotic 
symptoms (FEP, ARMS-ST) thus could reach the peak of the inverted U-curve sooner than less 
symptomatic (ARMS-LT and HC) individuals.  Apart from that the behavioural differences may 
be due to attentional impairments seen in schizophrenia patients (Karch et al., 2009), the 
symptom severity, and medication. Previous studies report impaired working memory 
performance in the ARMS (Eastvold et al., 2007; Pflueger et al., 2007), although other studies 
find no effect on task performance (Broome et al., 2010; Broome et al., 2009; Fusar-Poli et al., 
2010a; Fusar-Poli et al., 2010b). However, functional neuroimaging techniques are able to detect 
physiological changes, and are likely to be more sensitive than behavioural measures (Wilkinson 
and Halligan, 2004). Furthermore, the image analyses were restricted to correct responses and the 
observed differential activations reflect differences at the neurophysiological level and not on 
task performance. 
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Overall, we found working memory-associated activations in the prefrontal and parietal cortex in 
all our subjects during WM task, corresponding to previously published data of patients with an 
ARMS (Broome et al., 2009; Fusar-Poli et al., 2010a) and psychosis (Callicott et al., 2003a; 
Callicott et al., 2003b; Forbes et al., 2009). Vulnerability-associated functional abnormalities in 
the superior frontal gyrus and in parietal lobules distinguished the ARMS-ST from HC group and 
corresponded to the previous fMRI studies with altered prefrontal brain activation (Fusar-Poli et 
al., 2009; Fusar-Poli et al., 2010b) for review see reference (Fusar-Poli et al., 2007). Compared to 
the HC, both the ARMS-ST and ARMS-LT groups showed reduced GMV in the anterior 
cingulate, middle and inferior frontal gyri. These findings are similar to the published volumetric 
abnormalities found in ARMS (Borgwardt et al., 2008; Borgwardt et al., 2007b; Fornito et al., 
2008; Koutsouleris et al., 2009; Meisenzahl et al., 2008; Pantelis et al., 2003; Sun et al., 2009). 
Interestingly, we found probably compensatory more GMV in insula in the ARMS-LT compared 
to the HC group. 
 
The neurofunctional reduction in the ARMS-ST versus ARMS-LT group revealed the 
difference between the higher and lower transition probability. Only one cluster in the right 
inferior frontal gyrus and insula distinguished these two groups after covarying for gray 
matter volume. Furthermore, reduced activation in the left inferior frontal gyrus, the right 
insula, and in the bilateral precuneus positively correlated with volumetric deficits in these 
regions within the ARMS-LT and ARMS-ST individuals, respectively. A previous study by 
Fusar-Poli et al. (Fusar-Poli et al., 2010a) showed that the prefrontal functional abnormalities 
in ARMS are related to GMV. Our results are comparable to the prefrontal abnormalities 
found in ARMS (Fusar-Poli et al., 2010a) and to the altered function found in precuneus in 
unaffected siblings of schizophrenia patients (Liu et al., 2010). Furthermore, reduced GMV 
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in the right temporal gyrus and insula delineate the difference between the ARMS-ST and 
the ARMS-LT group. These are the regions known to be different in ARMS with and 
without subsequent transition to psychosis (Borgwardt et al., 2007b). 
Comparing the FEP with ARMS-LT individuals, we observed functional differences in the 
bilateral inferior frontal gyrus and insula, and in left superior and middle frontal gyrus, that 
may delineate psychosis-associated changes. These functional alterations during the WM 
task resemble those reported previously in schizophrenia patients in prefrontal (Barch et al., 
2001; Cannon et al., 2005; Johnson et al., 2006; Manoach et al., 2000; Manoach et al., 1999; 
Menon et al., 2001; Perlstein et al., 2001; Tan et al., 2005), and temporal (Fusar-Poli et al., 
2007; Glahn et al., 2005; Karch et al., 2009; Schneider et al., 2007) regions. In agreement 
with our hypothesis, the ARMS-LT and the ARMS-ST groups showed more WM-related 
activation than the FEP and less than the HC group. We found neither neurofunctional nor 
behavioural differences between FEP and ARMS-ST group. Taking into account 20-30 % 
transition probability to the psychosis, the major part of this group will subsequently belong 
to the ARMS-LT group, physiologically different from the FEP group. We can deduce that 
the ARSM-LT group has not only lower transition probability (based on the published 
longitudinal study (Riecher-Rossler et al., 2009)) but as well some resilience factors, which 
helped those individuals to avoid the imminent psychosis.  
 
The ARMS is understood as a dynamic process (Simon and Umbricht, 2010; Yung et al., 
2010) concerning structural and functional brain abnormalities (Fusar-Poli et al., 2007), 
disrupted cellular integrity and connectivity (Green, 2007), and other still unknown factors. 
We showed that neurofunctional abnormalities are associated with structural deficits in the 
ARMS-ST and ARMS-LT groups, as they changed its significance in insular and inferior 
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and superior frontal regions after covarying for GMV. Using a well-established working 
memory paradigm, we found functional vulnerability-associated abnormalities in a fronto-
parietal network, whereas abnormalities associated with psychosis itself in frontal and insular 
brain activations. We presume that dynamic processes in task-relevant regions underline 
positive functional-structural correlation in the early stages of ARMS (ARMS-ST, ARMS-
LT) and the negative correlation in the FEP group. It remains unknown, whether functional 
abnormalities precede the structural ones, how reversible they are, and if they are 
compensatory in their nature. In future, a multimodal approach combining fMRI and sMRI 
results with connectivity measurements or combining optical and genetic techniques(Lee et 
al., 2010b) could help to improve understanding of neural circuits underlying psychosis and 
ARMS. 
 
The neurofunctional abnormalities we observed could not directly be attributed to 
antipsychotic treatment, as all of the ARMS-ST were antipsychotic-naïve and only 12% of 
the ARMS-LT had antipsychotic treatment at the time of scanning. Although the exclusion 
of 38% antipsychotic-medicated FEP patients did not substantially change our results, we 
probably found a protective effect of antipsychotics in the subcortical structures. For all other 
comparisons after excluding medicated individuals from analyses the results remained 
largely unchanged. The influence of antipsychotics on the brain function is not entirely clear, 
however antipsychotics may affect neural activity (Lui et al., 2010) and GMV (Tost et al., 
2010), especially in basal ganglia (Smieskova et al., 2009). Furthermore, all of those on 
antipsychotics were treated with atypical compounds in very low doses.  
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Some limitations of this study should be considered. Firstly, although one subject of the 
ARMS-ST group developed psychosis during the follow-up, the small sample size did not 
allow meaningful analyses regarding the clinical outcome. Secondly, our specific FEP 
population included mostly outpatients at the beginning of their disease with relatively high 
premorbid IQ values compared to chronically ill psychotic patients at a later stage of the 
illness (Urfer-Parnas et al., 2010). Thirdly, although the FEP group had less formal education 
than the other groups, this could not account for the differences between the ARMS-ST and 
ARMS-LT and control groups, which were matched regarding these aspects. Fourthly, 
although the ARMS-ST group has a higher probability of transition to psychosis, thus there 
is a non-transition probability of approximately 70%. The neurofunctional differences found 
in this group could be even more pronounced in the pure transition subgroup. Fifthly, we 
have not examined the association with an affective psychosis, borderline personality 
disorder or other comorbidities with the ARMS. Assessment of other psychopathological 
measures could lead to better distinction characteristics of ARMS-ST and ARMS-LT group. 
However, this was not the main aim of the study. Sixthly, we have not studied the default 
mode network independent of the WM-task and cannot thus exclude the anomalous network 
connectivity (Whitfield-Gabrieli et al., 2009) in included individuals. Such functional 
connectivity analysis could extend the understanding of ARMS-underlying processes. 
Finally, the pure transition group could show more pronounced differences, but the 
differences seen even at the very early beginning of the ARMS in ARMS-ST, showed us the 
regions playing the crucial role in the dynamic ARMS process.  
 
CONCLUSION 
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In this study we found distinct patterns of mnemonic neurofunctional brain activation related 
to vulnerability to psychosis as opposed to psychosis itself. Neurofunctional alterations in 
fronto-parietal regions may be correlates of vulnerability to psychosis whereas more 
pronounced neurofunctional abnormalities in prefrontal cortex were associated with the 
presence of psychosis. Our results thus confirm the hypothesis of a disrupted working 
memory network during the development of psychosis. Additionally, neurofunctional 
differences within the ARMS were related to different duration of ARMS. These 
abnormalities were directly related to volumetric reduction. 
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FIGURE LEGENDS 
 
Figure 1: Vulnerability-associated group differences in activation. 
 
The crosses show the peak area of different activation between the ARMS-ST and the HC 
groups. Clusters in the bilateral superior parietal lobule (x=-8; y=-64; z=48; voxels=2738, 
panel A), in the left superior frontal gyrus (-12 0 62; voxels=312, panel B), and in the right 
inferior and superior parietal lobule (48 -44 52; voxels=741, panel C) reflect decreased 
regional brain activation in the ARMS-ST as compared to the HC group during the 2-back>0-
back task (P<0.05). Covarying for GMV had no effect on these results. The left side of the 
brain is shown on the left side of the images.  
 
Figure 2: Psychosis-associated group differences in activation. 
 
The crosses show the peak area of different activation between the FEP and the ARMS-LT 
groups. Clusters in the left inferior and orbital frontal gyrus and insula (x=-32; y=34; z=0; 
voxels=1568, panel A), in the left superior frontal gyrus (-14 0 60; voxels=402, panel B), and 
in the left inferior and middle frontal gyrus (-34 26 18; voxels=689, panel C) reflect 
decreased regional brain activation in the FEP as compared to the ARMS-LT group during 
the 2-back>0-back task (P<0.01). After covarying for GMV the cluster in the right inferior 
frontal gyrus and insula (26 22 2; voxels=406, panel D) became significant. The left side of 
the brain is shown on the left side of the images.  
 
Figure 3: Group differences in brain activation between the ARMS-ST and the ARMS-
LT groups.  
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The clusters reflect decreased regional brain activation in the right inferior frontal gyrus and 
insula (x=42; y=18; z=-4; voxels=303; P<0.05, panel A) and in bilateral precuneus (18 -78 48, 
voxels= 243, P<0.1, panel B) in ARMS-ST as compared to ARMS-LT group during the 2-
back>0-back task. Covarying for GMV caused loss of significance in left superior frontal 
gyrus (-10 -4 66, voxels= 229, panel C), and in left insula (-38 14 0, voxels= 224, P<0.01, 
panel D). The left side of the brain is shown on the left side of the images.  
 
 
 
